Richard Alan Lewis MD
Neuromuscular Medicine, Neurophysiology
Professor of Neurology Director, EMG Laboratory
Join to View Full Profile
127 South San Vicente BlvdLos Angeles, CA 90048
Phone+1 310-423-2372
Dr. Lewis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemResidency, Neurology, 1975 - 1978
Hartford HospitalInternship, Transitional Year, 1974 - 1975
Virginia Commonwealth University School of MedicineClass of 1974
Certifications & Licensure
CA State Medical License 2012 - 2027
MI State Medical License 1993 - 2015
CT State Medical License 1980 - 1984
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite (with Beaker), Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
- Trial of Resistance and Endurance Exercise in Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2012 Jan 01
- Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS) Start of enrollment: 2013 Aug 01
Publications & Presentations
PubMed
- Efgartigimod as a treatment for people with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): a plain language summary of publication of the ADHERE trial.Jeffrey A Allen, Luis Querol, Niraja Suresh, Anneleen Remmerie, Trevor Mole
Therapeutic Advances in Neurological Disorders. 2026-01-01 - 7 citationsVerdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial., Jinsy Andrews, Sabrina Paganoni, Eric A Macklin, Lori B Chibnik
JAMA Neurology. 2025-04-01 - 1 citationsParaneoplastic Leucine Zipper 4 IgG Associated Motor-Predominant Polyradiculoneuropathy.Alex Panrudkevich, Duaa Jabari, Brendan Putko, Catherine Daley, Richard A Lewis
Journal of the Peripheral Nervous System. 2025-03-01
Journal Articles
- Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral SclerosisBrian J Wainger, Nicholas J Maragakis, Richard Bedlack, Namita A Goyal, Seward B Rutkove, Michael H Rivner, Stephen A Goutman, Shafeeq S Ladha, Elizabeth A Mauricio, R..., JAMA Neurology
Press Mentions
Investigational Drugs for Chronic Inflammatory Demyelinating PolyneuropathyMay 8th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
